Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, and Cancer Immunotherapy and Biomarkers.
Aligning computational pathology with clinical practice for colorectal cancer
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study
Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study
Pseudobudding: ruptured glands do not represent true tumor buds
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore.
Pathologists' first opinions on barriers and facilitators of computational pathology adoption in oncological pathology: an international study.
Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer.
Tumour budding in solid cancers.
Dataset for Pathology Reporting of Colorectal Cancer
Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease
Refining the ITBCC tumor budding scoring system with a “zero-budding” category in colorectal cancer
Tumour budding and CD8<sup>+</sup> T cells: 'attackers' and 'defenders' in rectal cancer with and without neoadjuvant chemoradiotherapy.
Tumour budding in solid cancers
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer
Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn’s disease
Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning.
Correction to: Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning.
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?
Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients.
Melanoma and immunotherapy bridge 2015
Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
Cancer classification using the Immunoscore: a worldwide task force